- Unimicron’s net income for the first quarter fell short of expectations with NT$914.5 million, compared to an estimated NT$1.07 billion.
- The company reported a higher-than-expected operating profit of NT$1.27 billion, surpassing the anticipated NT$903.8 million.
- Earnings per share (EPS) were NT$0.60, below the projected NT$0.71.
- Revenue was stronger than expected, reaching NT$30.09 billion against an estimate of NT$28.95 billion.
- Analyst recommendations on Unimicron include 12 buys, 7 holds, and 2 sells.
A look at Unimicron Technology Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Unimicron Technology Corp., a company specializing in manufacturing printed circuit boards and providing integrated circuit services, demonstrates a positive long-term outlook based on its Smartkarma Smart Scores. With high scores in Value and Dividend factors, Unimicron Technology is perceived favorably in terms of its financial stability and potential for returns to investors. Additionally, the company’s Growth score indicates promising future expansion opportunities, albeit at a slightly lower level. Despite somewhat lower scores in Resilience and Momentum, the overall outlook remains positive for Unimicron Technology.
In summary, Unimicron Technology Corp. excels in Value and Dividend factors, showcasing financial strength and potential returns. With a solid foundation in manufacturing printed circuit boards and offering integrated circuit services, the company is positioned for long-term growth. While scores in Growth, Resilience, and Momentum vary, the overall outlook for Unimicron Technology suggests a promising future in the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
